Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease

PHASE3TerminatedINTERVENTIONAL
Enrollment

1,125

Participants

Timeline

Start Date

November 18, 2021

Primary Completion Date

December 30, 2024

Study Completion Date

December 30, 2024

Conditions
Alzheimer Disease
Interventions
DRUG

Simufilam

Simufilam is a novel drug candidate designed to treat and slow the progression of AD. Simufilam binds with femtomolar affinity to an altered conformation of filamin A that is present in the brain of patients with AD and critical to the toxicity of Aβ42. In this study, simufilam will be given b.i.d. for 76 weeks at a dose of 50 mg or 100 mg.

DRUG

Placebo

Matching placebo given b.i.d. for 76 weeks

Trial Locations (89)

10312

Richmond Behavioral Associates, Staten Island

11229

Integrative Clinical Trials, Brooklyn

11235

SPRI Clinical Trials Brooklyn, Brooklyn

11923

Hanyang University Guri Hospital, Guri-si

12208

Albany Medical Center, Albany

Neurological Associates of Albany, Albany

13057

Velocity Clinical Research, Formerly Clarity Clinical Research, East Syracuse

13620

Seoul National University Bundang Hospital, Seongnam-si

19046

The Clinical Trial Center, Jenkintown

19462

Keystone Clinical Studies, LLC, Plymouth Meeting

21565

Gachon University Gil Hospital, Namdong-gu

22332

Inha University Medical Center, Incheon

27103

Accellacare Research of Winston-Salem, Winston-Salem

30030

Accel Research Sites - NeuroStudies, Decatur

31909

Columbus Memory Center, PC, Columbus

32751

K2 Medical Research, Maitland

32789

Conquest Research, Winter Park

32801

Clinical Neuroscience Solutions, Inc. dba CNS Healthcare, Orlando

33012

Indago Research and Health Center, Inc., Hialeah

33137

Mind Institute at Miami Jewish Health, Miami

33176

Brainstorm Research, Miami

33414

Alzheimer's Research & Treatment Center, Wellington

33442

Quantum Laboratories, Deerfield Beach

33445

Brain Matters Research Inc, Delray Beach

33458

Alphab Global Research, Jupiter

33462

JEM Research Institute, Atlantis

33486

Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton

33511

Clinical Research of Brandon, LLC, Brandon

33613

USF Health - Byrd Alzheimer's Center and Research Institute, Tampa

34239

Intercoastal Medical Group - Sarasota, Sarasota

34972

Health Synergy Clinical Research, Okeechobee

34997

Alzheimer's Research & Treatment Center, Stuart

Brain Matters Research Inc, Stuart

37067

KCA Neurology, PLLC, Franklin

40504

University of Kentucky Sanders-Brown Center on Aging, Lexington

43210

Ohio State University, Columbus

44720

Neuro-Behavioral Clinical Research (NBCR), North Canton

45459

Neurology Diagnostics, Dayton

53226

Medical College of Wisconsin, Milwaukee

60068

Advocate Aurora Health, Park Ridge

60640

Great Lakes Clinical Trials, Chicago

61469

Chonnam National University Hospital, Gwangju

Kyungpook National University Chilgok Hospital, Daegu

75062

Cedar Health Research, Irving

75243

Neurology Consultants of Dallas, PA, Dallas

85006

Banner Alzheimer's Institute, Phoenix

85032

Arizona Neuroscience Research, LLC, Phoenix

85258

Clinical Endpoints, Scottsdale

85351

Banner Sun Health Research Institute, Sun City

85718

Banner Alzheimer's Institute - Tucson, Tucson

90027

California Research Insitute, Los Angeles

90804

Healthy Brain Clinic, Long Beach

92011

North County Neurology Associates, Carlsbad

92103

Pacific Research Network, LLC, San Diego

92663

Shankle Clinic and Hoag Memorial Hospital Presbyterian, Newport Beach

92835

Neurology Center of North Orange County, Fullerton

93710

Neuro-Pain Medical Center, Fresno

97225

Center for Cognitive Health - Portland, Portland

98007

Northwest Clinical Research Center, Bellevue

06810

Nuvance Health Medical Practice CT, Inc. - Associated Neurologists, PC, Danbury

06905

Ki Health Partners, LLC, Stamford

02035

Neurology Center of New England, Foxborough

01844

ActivMed Practices & Research, LLC, Methuen

02459

Boston Center for Memory, Newton

02360

Office of Donald S. Marks, M.D., P.C., Plymouth

02451

MedVadis Research, Waltham

07748

Patient First MD, Middletown

08540

Global Medical Institutes, LLC, Princeton

07081

The Cognitive and Research Center of New Jersey (CRCNJ), Springfield

08755

Advanced Memory Research Institute of NJ, Toms River

05201

The Memory Clinic - Bennington, Bennington

V1Y 2Z9

OCT Research ULC DBA Okanagan Clinical Trials, Kelowna

V6T 1Z3

Djavad Mowafaghian Centre for Brain Health, Vancouver

E1C 2Z3

Centre Hospitalier Universitaire Dr-Georges-L.-Dumont (CHUDGLD), Moncton

B3S 1N2

True North Clinical Research - Halifax, Halifax

B4N 3R7

True North Clinical Research - New Minas, New Minas

N6C 0A7

St. Joseph's Health Care London, London

K1Z 1G3

Ottawa Memory Clinic, Ottawa

Recherches Neuro-Hippocampe Inc., Ottawa

K9H2P4

Kawartha Centre - Redefining Healthy Aging, Peterborough

M3B 2S7

Toronto Memory Program, Toronto

Unknown

The Centre for Memory and Aging, Toronto

Instituto De Neurologia Dra. Ivonne Fraga, San Juan

00961

Santa Cruz Behavioral PSC, Bayamón

00918

Inspira Clinical Research, San Juan

00926

Barbara Diaz Hernandez Md Research, Inc., San Juan

02841

Korea University Anam Hospital, Seongbuk-gu

04763

HanYang University Hospital, Seongdong-gu

05505

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
collaborator

Premier Research Group plc

UNKNOWN

lead

Cassava Sciences, Inc.

INDUSTRY

NCT05026177 - Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease | Biotech Hunter | Biotech Hunter